Related Experiment Video
Updated: Aug 21, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk
Giuseppe Mercuro1, Cristiana Vitale, Elena Cerquetani
1Department of Cardiovascular Sciences, University of Cagliari, Cagliari, Italy. mercuro@pacs.unica.it <mercuro@pacs.unica.it>
Abstract:
The aim of the present study was to evaluate the effect of increased serum uric acid (UA) levels and their therapeutic reduction with allopurinol on endothelium-dependent dilation in subjects with a high cardiovascular (CV) risk but who were free from clinical CV disease. Patients with hyperuricemia had impaired flow-mediated dilation (FMD) compared with matched controls with normal UA levels and elevated CV risk. Three-month therapy with allopurinol improved FMD in hyperuricemic subjects, showing an intrinsic negative effect of elevated UA levels on the arterial wall; conversely, FMD remained unchanged in controls, thus suggesting that the reduction of UA to less than a certain value does not affect endothelial function.
Related Concept Videos
Atherosclerosis III: Management
Hypertension II: Pathophysiology
Coronary Artery Disease I: Introduction
Antihypertensive Drugs: Action of Diuretics
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension III: Clinical Manifestations and Diagnostic Studies
